Standardized warfarin monitoring decreases adverse drug reactions.
Lisa B E ShieldsPaula FowlerDiane M SiemensDouglas J LorenzKenneth C WilsonSteven T HesterJoshua T HonakerPublished in: BMC family practice (2019)
This study serves as a model to reduce the number of severe warfarin ADRs by the following tactics: (1) educating PCPs and cardiologists about evidence-based guidelines for warfarin management, (2) increasing the use of our Institution's electronic warfarin module, and (3) enhancing patient compliance with obtaining INR.